INBS vs. BTCY, OSA, VAPO, NXGL, PSTV, TTOO, GCTK, NURO, VVOS, and AVGR
Should you be buying Intelligent Bio Solutions stock or one of its competitors? The main competitors of Intelligent Bio Solutions include Biotricity (BTCY), ProSomnus (OSA), Vapotherm (VAPO), NEXGEL (NXGL), Plus Therapeutics (PSTV), T2 Biosystems (TTOO), GlucoTrack (GCTK), NeuroMetrix (NURO), Vivos Therapeutics (VVOS), and Avinger (AVGR). These companies are all part of the "surgical & medical instruments" industry.
Biotricity (NASDAQ:BTCY) and Intelligent Bio Solutions (NASDAQ:INBS) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, valuation, profitability, institutional ownership, risk, community ranking and earnings.
Biotricity has a beta of 1.51, suggesting that its share price is 51% more volatile than the S&P 500. Comparatively, Intelligent Bio Solutions has a beta of 4.82, suggesting that its share price is 382% more volatile than the S&P 500.
3.9% of Biotricity shares are held by institutional investors. Comparatively, 33.0% of Intelligent Bio Solutions shares are held by institutional investors. 20.5% of Biotricity shares are held by company insiders. Comparatively, 0.3% of Intelligent Bio Solutions shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
In the previous week, Intelligent Bio Solutions had 2 more articles in the media than Biotricity. MarketBeat recorded 4 mentions for Intelligent Bio Solutions and 2 mentions for Biotricity. Biotricity's average media sentiment score of 0.44 beat Intelligent Bio Solutions' score of 0.00 indicating that Intelligent Bio Solutions is being referred to more favorably in the news media.
Intelligent Bio Solutions has lower revenue, but higher earnings than Biotricity. Biotricity is trading at a lower price-to-earnings ratio than Intelligent Bio Solutions, indicating that it is currently the more affordable of the two stocks.
Biotricity has a net margin of -125.43% compared to Biotricity's net margin of -544.63%. Intelligent Bio Solutions' return on equity of 0.00% beat Biotricity's return on equity.
Biotricity and Intelligent Bio Solutions both received 0 outperform votes by MarketBeat users.
Summary
Intelligent Bio Solutions beats Biotricity on 8 of the 13 factors compared between the two stocks.
Get Intelligent Bio Solutions News Delivered to You Automatically
Sign up to receive the latest news and ratings for INBS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding INBS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Intelligent Bio Solutions Competitors List
Related Companies and Tools